Last reviewed · How we verify

NCT05975710

Textbook and Survival Outcomes of MIPD in South Korea

Completed Last updated 4 August 2023
What this trial tests

trial in Surgery-Complications in 1,552 participants. Completed in 1 March 2023.

Timeline
1 April 2020
Primary endpoint
31 December 2022
1 March 2023

Quick facts

Lead sponsorAsan Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,552
Start date1 April 2020
Primary completion31 December 2022
Estimated completion1 March 2023
Sites1 location across South Korea

Conditions studied

Sponsor

Asan Medical Center

Who can join

Eligibility, any sex, with Surgery-Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the current status of minimally invasive pancreatoduodenectomy (MIPD) in South Korea with regard to demographics, perioperative outcomes, risk factors for textbook outcome of pancreatic surgery (TOPS) and survival outcomes of periampullary cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Perioperative textbook outcomes of minimally invasive pancreatoduodenectomy: a multicenter retrospective cohort analysis in a Korean minimally invasive pancreatic surgery registry.
    Kwon J, Kang CM, Jang JY, Yoon YS, et al · · 2024 · cited 5× · PMID 38573082 · DOI 10.1097/js9.0000000000001390

Verify or expand the search:

Other recruiting trials for Surgery-Complications

Currently open trials in the same condition.

Other Asan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05975710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing